Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis.
Jin P, Jiang J, Zhou L, Huang Z, Qin S, Chen HN, Peng L, Zhang Z, Li B, Luo M, Zhang T, Ming H, Ding N, Li L, Xie N, Gao W, Zhang W, Nice EC, Wei Y, Huang C.
Jin P, et al. Among authors: zhang w, zhang t, zhang z.
EMBO Mol Med. 2022 Dec 7;14(12):e16082. doi: 10.15252/emmm.202216082. Epub 2022 Nov 2.
EMBO Mol Med. 2022.
PMID: 36321555
Free PMC article.